Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Evaluate's commercial intelligence on the pharmaceutical, biotechnology, and medical device industries is consistently referenced by leading business and industry publications such as the Financial Times, Wall Street Journal, and Nature.
Download our latest Media Kit for a forward-looking view of top companies, products, and more to support your editorial content.
Vantage releases annual analysis of Pharma, Biotech and Medtech performance
Vantage’s Annual Pharma and Biotech Preview explores what’s in store for 2019
Evaluate Ltd. releases annual “EvaluateMedtech World Preview 2018, Outlook to 2024” in conjunction with The Medtech Conference
Moreover, biotechnology drugs are contributing to sales at a large scale. For EvaluatePharma, these products will represent 31 percent of the market in 2024 in comparison…
In biopharma, the big R&D quest these days is building new blockbusters. And this list of the top 10 blockbusters drawn together for Nature Reviews Drug Discovery by…
In the pharmaceutical industry, there are typically 50–120 consolidative deals each year through which two companies become a single entity. So, it could be reasonable to…